GSE150895 GSE150896 enzalutamide 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE150895_GSE150896_enzalutamide_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE150895_GSE150896_enzalutamide_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE150895_GSE150896_enzalutamide_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE150895_GSE150896_enzalutamide_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

adhesion molecule with Ig like domain 2

Gene

joining chain of multimeric IgA and IgM

Gene

stearoyl-CoA desaturase

Gene

solute carrier family 38 member 1

Gene

A-kinase anchoring protein 12

Gene

insulin receptor substrate 2

Gene

glycoprotein nmb

Gene

aldehyde dehydrogenase 1 family member A3

Gene

solute carrier family 7 member 11

Gene

Purkinje cell protein 4

  • Gene

    adhesion molecule with Ig like domain 2


  • Gene

    joining chain of multimeric IgA and IgM


  • Gene

    stearoyl-CoA desaturase


  • Gene

    solute carrier family 38 member 1


  • Gene

    A-kinase anchoring protein 12


  • Gene

    insulin receptor substrate 2


  • Gene

    glycoprotein nmb


  • Gene

    aldehyde dehydrogenase 1 family member A3


  • Gene

    solute carrier family 7 member 11


  • Gene

    Purkinje cell protein 4

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.